1. Home
  2. CRCT vs ELVN Comparison

CRCT vs ELVN Comparison

Compare CRCT & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRCT
  • ELVN
  • Stock Information
  • Founded
  • CRCT 1969
  • ELVN 2016
  • Country
  • CRCT United States
  • ELVN United States
  • Employees
  • CRCT N/A
  • ELVN N/A
  • Industry
  • CRCT Wholesale Distributors
  • ELVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRCT Industrials
  • ELVN Health Care
  • Exchange
  • CRCT Nasdaq
  • ELVN Nasdaq
  • Market Cap
  • CRCT 1.3B
  • ELVN 1.2B
  • IPO Year
  • CRCT 2021
  • ELVN 2020
  • Fundamental
  • Price
  • CRCT $5.56
  • ELVN $20.19
  • Analyst Decision
  • CRCT Sell
  • ELVN Strong Buy
  • Analyst Count
  • CRCT 3
  • ELVN 5
  • Target Price
  • CRCT $4.52
  • ELVN $41.20
  • AVG Volume (30 Days)
  • CRCT 766.0K
  • ELVN 563.5K
  • Earning Date
  • CRCT 11-04-2025
  • ELVN 11-12-2025
  • Dividend Yield
  • CRCT 17.15%
  • ELVN N/A
  • EPS Growth
  • CRCT 8.68
  • ELVN N/A
  • EPS
  • CRCT 0.34
  • ELVN N/A
  • Revenue
  • CRCT $711,945,000.00
  • ELVN N/A
  • Revenue This Year
  • CRCT N/A
  • ELVN N/A
  • Revenue Next Year
  • CRCT $0.77
  • ELVN $20.05
  • P/E Ratio
  • CRCT $16.46
  • ELVN N/A
  • Revenue Growth
  • CRCT N/A
  • ELVN N/A
  • 52 Week Low
  • CRCT $3.94
  • ELVN $13.30
  • 52 Week High
  • CRCT $7.33
  • ELVN $30.03
  • Technical
  • Relative Strength Index (RSI)
  • CRCT 31.32
  • ELVN 52.19
  • Support Level
  • CRCT $6.21
  • ELVN $19.02
  • Resistance Level
  • CRCT $6.48
  • ELVN $20.66
  • Average True Range (ATR)
  • CRCT 0.26
  • ELVN 1.04
  • MACD
  • CRCT -0.13
  • ELVN 0.10
  • Stochastic Oscillator
  • CRCT 1.82
  • ELVN 71.76

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: